热熔挤压,喷雾干燥和KinetiSol®处理的比较研究,以制定一种水溶性和热稳定性差的药物

IF 5.3 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Miguel O. Jara , Beatriz Behrend-Keim , Giselle Bedogni , Lina Vargas Michelena , Daniel A. Davis Jr , Dave A. Miller , Claudio Salomon , Robert O. Williams III
{"title":"热熔挤压,喷雾干燥和KinetiSol®处理的比较研究,以制定一种水溶性和热稳定性差的药物","authors":"Miguel O. Jara ,&nbsp;Beatriz Behrend-Keim ,&nbsp;Giselle Bedogni ,&nbsp;Lina Vargas Michelena ,&nbsp;Daniel A. Davis Jr ,&nbsp;Dave A. Miller ,&nbsp;Claudio Salomon ,&nbsp;Robert O. Williams III","doi":"10.1016/j.ijpharm.2025.125582","DOIUrl":null,"url":null,"abstract":"<div><div>Fenbendazole (FBZ), a benzimidazole-carbamate anthelmintic, shows promising chemotherapeutic properties. However, it is a poorly water-soluble molecule, leading to low and variable oral bioavailability. This study investigated hot-melt extrusion (HME), spray drying, and KinetiSol processing (KSD) using Soluplus (SOL) to enhance FBZ’s solubility. Formulating FBZ as an amorphous solid dispersion (ASD) by HME at a barrel temperature of 120 °C led to extensive chemical degradation of FBZ, generating the degradation product fenbendazoleamine. On the other hand, spray-drying (SD) generated an ASD, but its usefulness was greatly limited by the low solubility of FBZ in the cosolvent system required in the SD process. Given FBZ’s poor solubility in both water and organic solvents and its thermolabile propensity, KSD was explored. Conventional KSD parameters reduced the impurity levels to 6.4 % at a discharge temperature of 64 °C. To further minimize impurity levels, we investigated alternative KSD parameters that terminate the process before reaching the melt agglomeration phase. These conditions resulted in powder-discharged KSD samples (pKSD) that avoided causing chemical degradation of FBZ. The pKSD samples exhibited trace crystallinity, as confirmed by Wide Angle X-ray Scattering (WAXS). Scanning electron microscopy (SEM) revealed that these samples comprised nano- and micron-sized particle aggregates. These results were confirmed by processing FBZ with other excipients, such as semi-crystalline polymers and cyclodextrins. The pKSD samples demonstrated improved dissolution performance of FBZ compared to the physical mixture and crystalline neat FBZ due to the smaller particle size of FBZ. pKSD FBZ provides a solution for formulating thermolabile molecules like FBZ while only requiring a few seconds of exposure to the pKSD manufacturing process conditions, thus eliminating the disadvantages of SD (e.g., requiring sufficiently high solubility in the organic solvent system) and HME (e.g., exposure to high shear and heat during the process).</div></div>","PeriodicalId":14187,"journal":{"name":"International Journal of Pharmaceutics","volume":"676 ","pages":"Article 125582"},"PeriodicalIF":5.3000,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparative study of Hot-Melt Extrusion, spray drying, and KinetiSol® processing to formulate a poorly water-soluble and thermolabile drug\",\"authors\":\"Miguel O. Jara ,&nbsp;Beatriz Behrend-Keim ,&nbsp;Giselle Bedogni ,&nbsp;Lina Vargas Michelena ,&nbsp;Daniel A. Davis Jr ,&nbsp;Dave A. Miller ,&nbsp;Claudio Salomon ,&nbsp;Robert O. Williams III\",\"doi\":\"10.1016/j.ijpharm.2025.125582\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Fenbendazole (FBZ), a benzimidazole-carbamate anthelmintic, shows promising chemotherapeutic properties. However, it is a poorly water-soluble molecule, leading to low and variable oral bioavailability. This study investigated hot-melt extrusion (HME), spray drying, and KinetiSol processing (KSD) using Soluplus (SOL) to enhance FBZ’s solubility. Formulating FBZ as an amorphous solid dispersion (ASD) by HME at a barrel temperature of 120 °C led to extensive chemical degradation of FBZ, generating the degradation product fenbendazoleamine. On the other hand, spray-drying (SD) generated an ASD, but its usefulness was greatly limited by the low solubility of FBZ in the cosolvent system required in the SD process. Given FBZ’s poor solubility in both water and organic solvents and its thermolabile propensity, KSD was explored. Conventional KSD parameters reduced the impurity levels to 6.4 % at a discharge temperature of 64 °C. To further minimize impurity levels, we investigated alternative KSD parameters that terminate the process before reaching the melt agglomeration phase. These conditions resulted in powder-discharged KSD samples (pKSD) that avoided causing chemical degradation of FBZ. The pKSD samples exhibited trace crystallinity, as confirmed by Wide Angle X-ray Scattering (WAXS). Scanning electron microscopy (SEM) revealed that these samples comprised nano- and micron-sized particle aggregates. These results were confirmed by processing FBZ with other excipients, such as semi-crystalline polymers and cyclodextrins. The pKSD samples demonstrated improved dissolution performance of FBZ compared to the physical mixture and crystalline neat FBZ due to the smaller particle size of FBZ. pKSD FBZ provides a solution for formulating thermolabile molecules like FBZ while only requiring a few seconds of exposure to the pKSD manufacturing process conditions, thus eliminating the disadvantages of SD (e.g., requiring sufficiently high solubility in the organic solvent system) and HME (e.g., exposure to high shear and heat during the process).</div></div>\",\"PeriodicalId\":14187,\"journal\":{\"name\":\"International Journal of Pharmaceutics\",\"volume\":\"676 \",\"pages\":\"Article 125582\"},\"PeriodicalIF\":5.3000,\"publicationDate\":\"2025-04-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Pharmaceutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0378517325004193\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378517325004193","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

芬苯达唑(FBZ)是一种苯并咪唑-氨基甲酸酯类驱虫药,具有良好的化疗性能。然而,它是一种水溶性较差的分子,导致口服生物利用度低且多变。本研究研究了热熔挤压(HME)、喷雾干燥和使用Soluplus (SOL)的KinetiSol处理(KSD)来提高FBZ的溶解度。在120℃的桶温下,HME法制备FBZ为无定形固体分散体(ASD), FBZ被广泛的化学降解,生成降解产物芬苯达唑胺。另一方面,喷雾干燥(SD)产生ASD,但其实用性受到SD工艺所需的助溶剂体系中FBZ溶解度低的限制。考虑到FBZ在水和有机溶剂中的溶解度较差,以及它的热稳定性,研究了KSD。在放电温度为64℃时,常规KSD参数可将杂质含量降低至6.4%。为了进一步减少杂质水平,我们研究了在达到熔体团聚阶段之前终止该过程的替代KSD参数。这些条件导致粉末排出的KSD样品(pKSD)避免了FBZ的化学降解。广角x射线散射(WAXS)证实,pKSD样品显示出微量结晶度。扫描电子显微镜(SEM)显示,这些样品包括纳米和微米大小的颗粒聚集体。用半结晶聚合物和环糊精等辅料对FBZ进行加工,证实了上述结果。由于FBZ的粒径较小,pKSD样品比物理混合物和结晶纯FBZ具有更好的溶解性能。pKSD FBZ提供了一种配制FBZ等耐热分子的解决方案,同时只需要在pKSD制造工艺条件下暴露几秒钟,从而消除了SD(例如,要求在有机溶剂体系中具有足够高的溶解度)和HME(例如,在过程中暴露于高剪切和高热量)的缺点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Comparative study of Hot-Melt Extrusion, spray drying, and KinetiSol® processing to formulate a poorly water-soluble and thermolabile drug

Comparative study of Hot-Melt Extrusion, spray drying, and KinetiSol® processing to formulate a poorly water-soluble and thermolabile drug
Fenbendazole (FBZ), a benzimidazole-carbamate anthelmintic, shows promising chemotherapeutic properties. However, it is a poorly water-soluble molecule, leading to low and variable oral bioavailability. This study investigated hot-melt extrusion (HME), spray drying, and KinetiSol processing (KSD) using Soluplus (SOL) to enhance FBZ’s solubility. Formulating FBZ as an amorphous solid dispersion (ASD) by HME at a barrel temperature of 120 °C led to extensive chemical degradation of FBZ, generating the degradation product fenbendazoleamine. On the other hand, spray-drying (SD) generated an ASD, but its usefulness was greatly limited by the low solubility of FBZ in the cosolvent system required in the SD process. Given FBZ’s poor solubility in both water and organic solvents and its thermolabile propensity, KSD was explored. Conventional KSD parameters reduced the impurity levels to 6.4 % at a discharge temperature of 64 °C. To further minimize impurity levels, we investigated alternative KSD parameters that terminate the process before reaching the melt agglomeration phase. These conditions resulted in powder-discharged KSD samples (pKSD) that avoided causing chemical degradation of FBZ. The pKSD samples exhibited trace crystallinity, as confirmed by Wide Angle X-ray Scattering (WAXS). Scanning electron microscopy (SEM) revealed that these samples comprised nano- and micron-sized particle aggregates. These results were confirmed by processing FBZ with other excipients, such as semi-crystalline polymers and cyclodextrins. The pKSD samples demonstrated improved dissolution performance of FBZ compared to the physical mixture and crystalline neat FBZ due to the smaller particle size of FBZ. pKSD FBZ provides a solution for formulating thermolabile molecules like FBZ while only requiring a few seconds of exposure to the pKSD manufacturing process conditions, thus eliminating the disadvantages of SD (e.g., requiring sufficiently high solubility in the organic solvent system) and HME (e.g., exposure to high shear and heat during the process).
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
10.70
自引率
8.60%
发文量
951
审稿时长
72 days
期刊介绍: The International Journal of Pharmaceutics is the third most cited journal in the "Pharmacy & Pharmacology" category out of 366 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信